Rheumatology

Aims & Scope

Rheumatology strives to support research and discovery by publishing the highest quality original scientific papers with a focus on basic, clinical and translational research.

The journal’s subject areas cover a wide range of paediatric and adult rheumatological conditions from an international perspective.

It is an official journal of the British Society for Rheumatology, published by Oxford University Press.

Rheumatology publishes original articles, reviews, editorials, guidelines, concise reports, meta-analyses, original case reports, clinical vignettes, letters and matters arising from published material.

The journal takes pride in serving the global rheumatology community, with a focus on high societal impact in the form of podcasts, videos and extended social media presence, and utilizing metrics such as Altmetric.

Keep up to date by following the journal on Twitter @RheumJnl.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.4
2024	4.70

SJR (SCImago Journal Rank)

Year	Value
2024	1.721

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	205

Journal Rank

Year	Value
2024	1864

Journal Citation Indicator

Year	Value
2024	8673

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A simplified disease activity index for rheumatoid arthritis for use in clinical practice

  Citation: 837

  Authors: J. S., F. C., M. H., J. R., P., G., P. L., P.

• The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis

  Citation: 711

  Authors: F., L., S., M.

• Transmembrane TNF- : structure, function and interaction with anti-TNF agents

  Citation: 707

  Authors: T., H., S.-i., H., T.

• Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis

  Citation: 646

  Authors: E.

• Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D)

  Citation: 639

  Authors: N. P., P., D., M., A.

• Neutrophil function in inflammation and inflammatory diseases

  Citation: 600

  Authors: H. L., R. J., R. C., S. W.

• The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies

  Citation: 568

  Authors: Frances, Michael, Matthew J, Peter, Weiya

• Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

  Citation: 547

  Authors: J. B., K. L., L. K., W. G., B., A. P., K. D., M., D. P. M.

• BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus

  Citation: 538

  Authors: D. A., A., E., V., M., I. N., D., B., M., P., N., M., L. S., C. S., A., C.

• Oral corticosteroids and fracture risk: relationship to daily and cumulative doses

  Citation: 538

  Authors: T. P., H. G. M., L., B., C.

---